Texas Recap

Category: Health

Global Health at a Crossroads: UN and WHO Tackle Patient Safety, AMR, and Toxic Chemical Exposure

Global Health at a Crossroads: UN and WHO Tackle Patient Safety, AMR, and Toxic Chemical Exposure

Marisol Vega|September 15, 2024

FDA Greenlights Major Advancements in Dermatology and Rare Disease Treatments

FDA Greenlights Major Advancements in Dermatology and Rare Disease Treatments

Marisol Vega|September 8, 2024

Rising Mpox Cases in the Philippines and Renewed U.S. Focus on UTI Treatment

Rising Mpox Cases in the Philippines and Renewed U.S. Focus on UTI Treatment

Marisol Vega|September 1, 2024

FDA Accelerates Drug Approvals as Global Agencies Confront Mpox Threat

FDA Accelerates Drug Approvals as Global Agencies Confront Mpox Threat

Marisol Vega|August 22, 2024

FDA Fast-Tracks Critical Drug Reviews Amid Rising Mpox Vaccination Drives in Africa Date:

FDA Fast-Tracks Critical Drug Reviews Amid Rising Mpox Vaccination Drives in Africa Date:

Marisol Vega|August 15, 2024

Texas Power Grid Under Pressure Amid Record-Breaking Heat and Surge in Energy Needs

Marisol Vega|August 10, 2024

Global Health at a Crossroads: Mpox Crisis Deepens in Africa as MDMA Therapy Nears FDA Decision

Global Health at a Crossroads: Mpox Crisis Deepens in Africa as MDMA Therapy Nears FDA Decision

Marisol Vega|August 8, 2024

Advances in Cancer Prevention, Digital Diagnostics, and Allergy Treatment

Advances in Cancer Prevention, Digital Diagnostics, and Allergy Treatment

Marisol Vega|August 1, 2024

FDA Accelerates Approvals in Rare Oncology and Boosts Global Hepatitis Awareness

FDA Accelerates Approvals in Rare Oncology and Boosts Global Hepatitis Awareness

Marisol Vega|July 22, 2024

FDA Announces Breakthrough Drug Approvals and WHO Revitalizes Global HIV Strategy

FDA Announces Breakthrough Drug Approvals and WHO Revitalizes Global HIV Strategy

Marisol Vega|July 15, 2024

‹ Newer Posts/Older Posts ›